Retrospective review of primary melanomas excised at Waikato Hospital, New Zealand, 2002-2003

Australasian Journal of Dermatology

Volumn 48, Issue 1, 2007, Pages 14-17

  Barker, Scott ^a,b   Oakley, Amanda ^a   Rademaker, Marius ^a  

^a WAIKATO HOSPITAL   (New Zealand)

^b NONE   (United Kingdom)

Author keywords

Early detection of melanoma; Early diagnosis; Excision waiting time; First specialist assessment waiting time; Malignant melanoma; Melanoma diagnosis; Waiting list

Indexed keywords

ADULT; AGED; CANCER SURGERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEW ZEALAND; REVIEW; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALS, SPECIAL; HUMANS; MALE; MEDICAL RECORDS; MELANOMA; MIDDLE AGED; NEW ZEALAND; OUTCOME ASSESSMENT (HEALTH CARE); REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; WAITING LISTS;

EID: 33845980217     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2007.00319.x     Document Type: Review

References (14)

1. Health Statistics, New Zealand Health Information Service. Cancer Registrations and Deaths 2001. 2006. Available from URL: http://www.nzhis.govt.nz. (Accessed 4 Apr 2006.)
2. Statistics New Zealand. Ethnic Population Projections: Issues and Trends - Article. 2004. Available from URL: http://www.stats.govt.nz/ products-and-services/Articles/pop-proj-Jun04.htm. (Accessed 2 Jul 2006.)
3. Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Moller T, Sjodin H, Stierner U, Wagenius G, Swedish Melanoma Study Group. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer 2004; 101: 2067-78.
4. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is physician detection associated with thinner melanomas? JAMA 1999; 281: 640-3.
5. Tyler I, Rivers J, Shoveller J, Blum A. Melanoma detection in British Columbia, Canada. J. Am. Acad. Dermatol. 2005; 52: 48-54.
6. McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. J. Am. Acad. Dermatol. 2006; 54: 783-92.
7. Clark W. A classification of malignant melanoma in man correlated with histogenesis and biologic behaviour. In: Montagna W, Hu F (eds). Advances in Biology of Skin. Oxford: Pergamon Press, 1967; 621-47.
8. Johnson T, Dolan O, Hamilton T, Lu M, Swanson N, Lowe L. Clinical and histologic trends of melanoma. J. Am. Acad. Dermatol. 1998; 38: 681-6.
9. Jones W, Harman R, Ng A, Shaw J. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world. World J. Surg. 1999; 23: 732-5.
10. Rhodes AR. Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer 1995; 75 (Suppl. 2): 613-36.
11. Ernstoff MS. Melanoma. Screening and education. Clin. Plast. Surg. 2000; 27: 317-22.
12. Guidelines, Elective Services, New Zealand Ministry of Health. Dermatology National Referral Guidelines. 2000. Available from URL: http://www.electiveservices.govt.nz/pdfs/Dermatology-Referral.pdf. (Accessed 10 Aug 2005.)
13. Temoshok L, DiClemente RJ, Sweet DM, Blois MS, Sagebiel RW. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984; 54: 3048-53.
14. National Institute for Health and Clinical Excellence. Cancer Service Guidance: Improving Outcomes for People with Skin Tumours including Melanoma, Second Consultation - The Manual, pp. 33-34. 2005. Available from URL: http://www.nice.org.uk/pdf/skin_tumours_2ndcons_fullguidance.pdf. (Accessed 18 Dec 2005.)